These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 35174594)

  • 1. Randomised controlled cognition trials in remitted patients with mood disorders published between 2015 and 2021: A systematic review by the International Society for Bipolar Disorders Targeting Cognition Task Force.
    Miskowiak KW; Seeberg I; Jensen MB; Balanzá-Martínez V; Del Mar Bonnin C; Bowie CR; Carvalho AF; Dols A; Douglas K; Gallagher P; Hasler G; Lafer B; Lewandowski KE; López-Jaramillo C; Martinez-Aran A; McIntyre RS; Porter RJ; Purdon SE; Schaffer A; Stokes P; Sumiyoshi T; Torres IJ; Van Rheenen TE; Yatham LN; Young AH; Kessing LV; Burdick KE; Vieta E
    Bipolar Disord; 2022 Jun; 24(4):354-374. PubMed ID: 35174594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of established and off-label ADHD drug therapies for cognitive impairment or attention-deficit hyperactivity disorder symptoms in bipolar disorder: A systematic review by the ISBD Targeting Cognition Task Force.
    Miskowiak KW; Obel ZK; Guglielmo R; Bonnin CDM; Bowie CR; Balanzá-Martínez V; Burdick KE; Carvalho AF; Dols A; Douglas K; Gallagher P; Kessing LV; Lafer B; Lewandowski KE; López-Jaramillo C; Martinez-Aran A; McIntyre RS; Porter RJ; Purdon SE; Schaffer A; Stokes PRA; Sumiyoshi T; Torres IJ; Van Rheenen TE; Yatham LN; Young AH; Vieta E; Hasler G
    Bipolar Disord; 2024 May; 26(3):216-239. PubMed ID: 38433530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can magnetic resonance imaging enhance the assessment of potential new treatments for cognitive impairment in mood disorders? A systematic review and position paper by the International Society for Bipolar Disorders Targeting Cognition Task Force.
    Miskowiak KW; Yalin N; Seeberg I; Burdick KE; Balanzá-Martínez V; Bonnin CDM; Bowie CR; Carvalho AF; Dols A; Douglas K; Gallagher P; Hasler G; Kessing LV; Lafer B; Lewandowski KE; López-Jaramillo C; Martinez-Aran A; McIntyre RS; Porter RJ; Purdon SE; Schaffer A; Sumiyoshi T; Torres IJ; Van Rheenen TE; Yatham LN; Young AH; Vieta E; Stokes PRA
    Bipolar Disord; 2022 Sep; 24(6):615-636. PubMed ID: 35950925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methodological recommendations for cognition trials in bipolar disorder by the International Society for Bipolar Disorders Targeting Cognition Task Force.
    Miskowiak KW; Burdick KE; Martinez-Aran A; Bonnin CM; Bowie CR; Carvalho AF; Gallagher P; Lafer B; López-Jaramillo C; Sumiyoshi T; McIntyre RS; Schaffer A; Porter RJ; Torres IJ; Yatham LN; Young AH; Kessing LV; Vieta E
    Bipolar Disord; 2017 Dec; 19(8):614-626. PubMed ID: 28895274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lurasidone versus treatment as usual for cognitive impairment in euthymic patients with bipolar I disorder: a randomised, open-label, pilot study.
    Yatham LN; Mackala S; Basivireddy J; Ahn S; Walji N; Hu C; Lam RW; Torres IJ
    Lancet Psychiatry; 2017 Mar; 4(3):208-217. PubMed ID: 28185899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing and addressing cognitive impairment in bipolar disorder: the International Society for Bipolar Disorders Targeting Cognition Task Force recommendations for clinicians.
    Miskowiak KW; Burdick KE; Martinez-Aran A; Bonnin CM; Bowie CR; Carvalho AF; Gallagher P; Lafer B; López-Jaramillo C; Sumiyoshi T; McIntyre RS; Schaffer A; Porter RJ; Purdon S; Torres IJ; Yatham LN; Young AH; Kessing LV; Vieta E
    Bipolar Disord; 2018 May; 20(3):184-194. PubMed ID: 29345040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effects of Transcranial Magnetic Stimulation on Cognitive Functioning in Bipolar Depression: A Systematic Review.
    Strelnik A; Strelnik S; Markina E; Zakharov A; Kolsanov A; Smirnova D
    Psychiatr Danub; 2022 Sep; 34(Suppl 8):179-188. PubMed ID: 36170725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Affective cognition in bipolar disorder: A systematic review by the ISBD targeting cognition task force.
    Miskowiak KW; Seeberg I; Kjaerstad HL; Burdick KE; Martinez-Aran A; Del Mar Bonnin C; Bowie CR; Carvalho AF; Gallagher P; Hasler G; Lafer B; López-Jaramillo C; Sumiyoshi T; McIntyre RS; Schaffer A; Porter RJ; Purdon S; Torres IJ; Yatham LN; Young AH; Kessing LV; Van Rheenen TE; Vieta E
    Bipolar Disord; 2019 Dec; 21(8):686-719. PubMed ID: 31491048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive enhancement treatments for bipolar disorder: A systematic review and methodological recommendations.
    Miskowiak KW; Carvalho AF; Vieta E; Kessing LV
    Eur Neuropsychopharmacol; 2016 Oct; 26(10):1541-61. PubMed ID: 27593623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic review of randomized controlled trials of candidate treatments for cognitive impairment in depression and methodological challenges in the field.
    Miskowiak KW; Ott CV; Petersen JZ; Kessing LV
    Eur Neuropsychopharmacol; 2016 Dec; 26(12):1845-1867. PubMed ID: 27745932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A meta-analytic investigation of cognitive remediation for mood disorders: Efficacy and the role of study quality, sample and treatment factors.
    Goldberg Z; Kuslak B; Kurtz MM
    J Affect Disord; 2023 Jun; 330():74-82. PubMed ID: 36868388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of personality disorder in randomised controlled trials of pharmacological interventions for adults with mood disorders: a protocol for a systematic review and meta-analysis.
    Kavanagh BE; Brennan-Olsen SL; Turner A; Dean OM; Berk M; Ashton MM; Koivumaa-Honkanen H; Williams LJ
    BMJ Open; 2019 May; 9(4):e025145. PubMed ID: 31048431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomised controlled trial of Interpersonal and Social Rhythm Therapy and group-based Cognitive Remediation versus Interpersonal and Social Rhythm Therapy alone for mood disorders: study protocol.
    Douglas KM; Inder ML; Crowe MT; Jordan J; Carlye D; Lacey C; Beaglehole B; Mulder R; Eggleston K; Donovan KA; Frampton CMA; Bowie CR; Porter RJ
    BMC Psychiatry; 2022 Feb; 22(1):115. PubMed ID: 35164720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations between cognition and subsequent mood episodes in patients with bipolar disorder and their unaffected relatives: A systematic review.
    Miskowiak KW; Mariegaard J; Jahn FS; Kjærstad HL
    J Affect Disord; 2022 Jan; 297():176-188. PubMed ID: 34699850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: A Systematic Review and Recommendations of Cannabis use in Bipolar Disorder and Major Depressive Disorder.
    Tourjman SV; Buck G; Jutras-Aswad D; Khullar A; McInerney S; Saraf G; Pinto JV; Potvin S; Poulin MJ; Frey BN; Kennedy SH; Lam RW; MacQueen G; Milev R; Parikh SV; Ravindran A; McIntyre RS; Schaffer A; Taylor VH; van Ameringen M; Yatham LN; Beaulieu S
    Can J Psychiatry; 2023 May; 68(5):299-311. PubMed ID: 35711159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive enhancement interventions for people with bipolar disorder: A systematic review of methodological quality, treatment approaches, and outcomes.
    Tsapekos D; Seccomandi B; Mantingh T; Cella M; Wykes T; Young AH
    Bipolar Disord; 2020 May; 22(3):216-230. PubMed ID: 31610086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of cognitive remediation on cognitive abilities and real-world functioning among people with bipolar disorder: A systematic review: Special Section on "Translational and Neuroscience Studies in Affective Disorders". Section Editor, Maria Nobile MD, PhD. This Section of JAD focuses on the relevance of translational and neuroscience studies in providing a better understanding of the neural basis of affective disorders. The main aim is to briefly summaries relevant research findings in clinical neuroscience with particular regards to specific innovative topics in mood and anxiety disorders.
    Bellani M; Biagianti B; Zovetti N; Rossetti MG; Bressi C; Perlini C; Brambilla P
    J Affect Disord; 2019 Oct; 257():691-697. PubMed ID: 31377606
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.